Pathogenesis of heparin-induced thrombocytopenia

GM Arepally, DB Cines - Translational Research, 2020 - Elsevier
There are currently no effective substitutes for high intensity therapy with unfractionated
heparin (UFH) for cardiovascular procedures based on its rapid onset of action, ease of …
被引用次数：90 相关文章

[引用][C] Pathogenesis of heparin-induced thrombocytopenia

GM Arepally, DB Cines - Translational Research, 2020 - hero.epa.gov

Pathogenesis of heparin-induced thrombocytopenia.

GM Arepally, DB Cines - … Research: the Journal of Laboratory and …, 2020 - europepmc.org
There are currently no effective substitutes for high intensity therapy with unfractionated
heparin (UFH) for cardiovascular procedures based on its rapid onset of action, ease of …
[HTML] nih.gov

[HTML][HTML] Pathogenesis of Heparin-Induced Thrombocytopenia

GM Arepally, DB Cines - … research: the journal of laboratory and …, 2020 - ncbi.nlm.nih.gov
There are currently no effective substitutes for high intensity therapy with unfractionated
heparin (UFH) for cardiovascular procedures based on its rapid onset of action, ease of …

Pathogenesis of heparin-induced thrombocytopenia

GM Arepally, DB Cines - Translational research: the …, 2020 - pubmed.ncbi.nlm.nih.gov
There are currently no effective substitutes for high intensity therapy with unfractionated
heparin (UFH) for cardiovascular procedures based on its rapid onset of action, ease of …

Pathogenesis of heparin-induced thrombocytopenia

GM Arepally, DB Cines - Translational Research, 2020 - translationalres.com
There are currently no effective substitutes for high intensity therapy with unfractionated
heparin (UFH) for cardiovascular procedures based on its rapid onset of action, ease of …